RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ROTA-SCALABRINI D
Collezione ASL Vercelli

Items : 3

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. in Blood / Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16.

2013
AOU Città della Salute di Torino
ASL Vercelli

Larocca A; Montefusco V; Bringhen S; Rossi D; Crippa C; Mina R; Galli M; Marcatti M; La Verde G; Giuliani N; Magarotto V; Guglielmelli T; Rota-Scalabrini D; Omedé P; Santagostino A; Baldi I; Carella AM; Boccadoro M; Corradini P; Palumbo A;

Salvage treatment with pomalidomide-cyclophosphamideprednisone produces similar outcomes as compared to prior therapies in patients with relapsed/refractory multiple myeloma in Haematologica

2013
ASL Vercelli

Larocca A; Montefusco V; Oliva S; Spriano M; Santagostino A; Genuardi M; Rota-Scalabrini D; Guglielmelli T; Giuliani N; Moscetti A; Mina R; Marcatti M; Galli M; Gilestro M; Crippa C; Baldi I; Rossi D; Boccadoro M; Corradini P; Palumbo A;

Pomalidomide cyclophosphamide and prednisone is active in lenalidomide relapsed/ refractory multiple myeloma in Clinical Lymphoma, Myeloma and Leukemia

2013
ASL Vercelli

Larocca A; Montefusco V; Oliva S; Rossi D; Crippa C; Genuardi M; Galli M; Marcatti M; Moscetti A; Giuliani N; Mina R; Guglielmelli T; Rota-Scalabrini D; Oddolo D; Santagostino A; Baldi I; Spriano M; Boccadoro M; Corradini P; Palumbo A;